Cargando…
LPM3770277, a Potent Novel CDK4/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer
Triple negative breast cancer (TNBC) is a subtype of breast cancer with significant malignancy and poor prognosis but effective treatments are limited. Given the critical role of CDK4/6 in cell cycle and the apparent success of CDK4/6 inhibitors against certain cancer, this study attempted to utiliz...
Autores principales: | Qiu, Jiahao, Bai, Xinfa, Zhang, Wenjing, Ma, Mingxu, Wang, Wenyan, Liang, Ye, Wang, Hongbo, Tian, Jingwei, Yu, Pengfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037595/ https://www.ncbi.nlm.nih.gov/pubmed/35479314 http://dx.doi.org/10.3389/fphar.2022.853993 |
Ejemplares similares
-
Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor
por: Zhang, Fangxi, et al.
Publicado: (2016) -
LPM580098, a Novel Triple Reuptake Inhibitor of Serotonin, Noradrenaline, and Dopamine, Attenuates Neuropathic Pain
por: Li, Nannan, et al.
Publicado: (2019) -
Subacute toxicity evaluations of LPM3480392 in rats, a full µ-opioid receptor biased agonist
por: Ye, Liang, et al.
Publicado: (2023) -
The Effects of LPM570065, a Novel Triple Reuptake Inhibitor, on Extracellular Serotonin, Dopamine and Norepinephrine Levels in Rats
por: Zhang, Renyu, et al.
Publicado: (2014) -
First indication of LPM effect in LHCf, an LHC experiment
por: del Prete, M
Publicado: (2016)